Results for this period
Interim period (second quarter)1 October 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ thousand).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Net sales increased because 2 customer projects involving particularly large electronic medical record system sales went live at the same time, and several projects scheduled for the third quarter onward went live ahead of schedule. Operating income and ordinary income also increased with the growth in electronic medical record system sales, but interim net income attributable to owners of the parent was in line with the year-earlier period because an impairment loss related to “Doctor Connect” was recorded.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 October 2025–31 March 2026 |
| Net Sales | 10,877 Millions of yen (YoY +18.2%) |
| Operating profit | 1,399 Millions of yen (YoY +13.7%) |
| Ordinary income | 1,424 Millions of yen (YoY +14.9%) |
| Profit attributable to owners of the parent | 708 Millions of yen (YoY +0.1%) |
| Net income per share | ¥42.54 |
| Equity ratio | End of the current fiscal period 57.9 / End of previous period 65.2 |
| Total assets | 14,091 Millions of yen |
| Net assets | 8,711 Millions of yen |
| Cash flows from operating activities | ¥3,023,532 thousand |
| Cash flows from investing activities | ¥-559,842 thousand |
| Cash flows from financing activities | ¥-413,031 thousand |
| Cash and cash equivalents at end of period | ¥7,083,409 thousand |
| Full-year earnings forecast | Net Sales 16,000 Millions of yen (YoY +1.1%) / Operating profit 1,600 Millions of yen (YoY +13.3%) / Ordinary income 1,600 Millions of yen (YoY +12.1%) / Profit attributable to owners of the parent 870 Millions of yen (YoY -44.2%) |
| Annual Dividend Forecast | ¥52 → ¥24（-53.8%） |
| Segment revenue | Healthcare Solutions business ¥10,605,365 thousand (YoY +19.4%), Marketing Solutions Business ¥272,069 thousand (YoY -14.1%) |
| Segment profit | Healthcare Solutions business ¥1,400,227 thousand (YoY +17.0%), Marketing Solutions Business ¥21,417 thousand (YoY -32.8%) |
| Orders received and order backlog | Orders received ¥7,908,774 thousand / Order backlog ¥2,927,009 thousand |
| Depreciation and amortization | ¥309,969 thousand |
| Impairment loss | ¥148,467 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Not disclosed / Extraordinary loss Impairment Losses ¥148,467 thousand |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 17,039,400 Shares |
| Treasury Shares at Period-End | 363,863 Shares |
| Factors Behind Changes in Business Performance | Net sales increased because 2 customer projects involving particularly large electronic medical record system sales went live at the same time, and several projects scheduled for the third quarter onward went live ahead of schedule. Operating income and ordinary income also increased with the growth in electronic medical record system sales, but interim net income attributable to owners of the parent was in line with the year-earlier period because an impairment loss related to “Doctor Connect” was recorded. |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Two large electronic medical record system projects went live at the same time, and several projects scheduled for the third quarter onward also went live ahead of schedule, increasing net sales, operating income and ordinary income. Meanwhile, the originally projected revenue from “Doctor Connect” was no longer expected, so an impairment loss of ¥148.467 million was recorded as an extraordinary loss. As a result, interim net income attributable to owners of the parent was in line with the year-earlier period.